![Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report | Journal of Medical Case Reports | Full Text Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report | Journal of Medical Case Reports | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13256-019-2071-2/MediaObjects/13256_2019_2071_Fig2_HTML.png)
Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report | Journal of Medical Case Reports | Full Text
![Effect of a single injection of cabergoline at dry off on udder characteristics in high-yielding dairy cows - Journal of Dairy Science Effect of a single injection of cabergoline at dry off on udder characteristics in high-yielding dairy cows - Journal of Dairy Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2118957010/2087255906/gr1.jpg)
Effect of a single injection of cabergoline at dry off on udder characteristics in high-yielding dairy cows - Journal of Dairy Science
![Cabergoline for Cushing's disease: a large retrospective multicenter study in: European Journal of Endocrinology Volume 176 Issue 3 (2017) Cabergoline for Cushing's disease: a large retrospective multicenter study in: European Journal of Endocrinology Volume 176 Issue 3 (2017)](https://eje.bioscientifica.com/view/journals/eje/176/3/images/large/full-305fig1.jpeg)
Cabergoline for Cushing's disease: a large retrospective multicenter study in: European Journal of Endocrinology Volume 176 Issue 3 (2017)
![Cabergoline for Cushing's disease: a large retrospective multicenter study in: European Journal of Endocrinology Volume 176 Issue 3 (2017) Cabergoline for Cushing's disease: a large retrospective multicenter study in: European Journal of Endocrinology Volume 176 Issue 3 (2017)](https://eje.bioscientifica.com/view/journals/eje/176/3/images/large/full-305fig2.jpeg)
Cabergoline for Cushing's disease: a large retrospective multicenter study in: European Journal of Endocrinology Volume 176 Issue 3 (2017)
![Suppression of prolactin and reduction of milk secretion by effect of cabergoline in lactating dairy ewes - Journal of Dairy Science Suppression of prolactin and reduction of milk secretion by effect of cabergoline in lactating dairy ewes - Journal of Dairy Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/6ab354dc-4a42-4428-8ca9-e908d3af9e04/gr1.jpg)
Suppression of prolactin and reduction of milk secretion by effect of cabergoline in lactating dairy ewes - Journal of Dairy Science
![Suppression of prolactin and reduction of milk secretion by effect of cabergoline in lactating dairy ewes - Journal of Dairy Science Suppression of prolactin and reduction of milk secretion by effect of cabergoline in lactating dairy ewes - Journal of Dairy Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d94c41cd-2ac8-4e50-984c-d4467a7062b4/gr3.jpg)
Suppression of prolactin and reduction of milk secretion by effect of cabergoline in lactating dairy ewes - Journal of Dairy Science
![A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1994/nejm_1994.331.issue-14/nejm199410063311403/production/images/img_medium/nejm199410063311403_f1.jpeg)
A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea | NEJM
![Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases | Endocrinology Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases | Endocrinology](https://www.frontiersin.org/files/Articles/416881/fendo-09-00625-HTML/image_m/fendo-09-00625-g001.jpg)
Frontiers | Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases | Endocrinology
![Cabergoline - A New Dopamine Agonist for the Therapy of Prolactinoma - NEPTCC Bulletin Newsletter Article - MGH Neuroendocrine and Pituitary Tumor Clinical Center - Massachusetts General Hospital - Harvard Medical School (HMS) Cabergoline - A New Dopamine Agonist for the Therapy of Prolactinoma - NEPTCC Bulletin Newsletter Article - MGH Neuroendocrine and Pituitary Tumor Clinical Center - Massachusetts General Hospital - Harvard Medical School (HMS)](https://pituitary.mgh.harvard.edu/images/e-s-962a.gif)